"Primary source for Venture Funding and Angel Investors"

Sign up to contact this member

 

Only investors and funding providers that are registered through us can view the attached business plan and contact this member for funding.

Contact Now »
BUSINESS PLAN
Where Hope Grows Stronger

Sarcomatrix, a specialty pharmaceutical company, is developing novel drugs to treat a variety of muscle wasting diseases, sarcopenia, cachexia and muscular dystrophies. Total market potential greater than $50B.

Project Image
Where Hope Grows Stronger
Sarcomatrix is set to transform DMD treatment within a $2 billion market, targeting a $18 billion opportunity by 2030 with innovative therapies. Backed by $8 million in NIH funds and investor support, we're advancing toward crucial trials.
Reno
Amount
$1,235,000